Healthy Adult ParticipantsSupplementsNutrition and dietExercise and fitnessHealthy volunteersHealthmaxxingDietary supplement
What this study is
The purpose of the present study was to examine the effectiveness of acute A-GPC supplementation on upper and lower body muscular strength, endurance, power, and global levels of activation.
What's being tested
- L-Alpha glycerylphosphorylcholine
Intervention · DIETARY SUPPLEMENT
- Microcrystalline Cellulose
Intervention · DIETARY SUPPLEMENT
Both interventions
Oral, 900 mg, single dose study
Study details
- Official title
- Effects of Alpha-GPC on Lower Body Muscular Performance and Activation.
- Sponsor
- Northern Illinois University
- Conditions
- Healthy Adult Participants
- Enrolling
- 20 people
- Starts
- 2026-03-16
- Est. completion
- 2026-05-16
- Design
- Double-blind, randomized, crossover
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 19 Years – 29 YearsSex MALEHealthy volunteers AcceptedYou may qualify if
- Recreationally-trained males, college-aged
You can't join if
- If the subjects report: 1) cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders; 2) use of any medications; 3) use of nutritional supplements; 4) habitual use of caffeine (≥1 caffeinated beverage per day); 5) participation in another clinical trial or investigation of another nutritional product within 30 days of screening/enrollment.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openNorthern Illinois University
DeKalb, Illinois, United States
- Clayton Camic, PHD · Contact3077607449ccamic1@niu.edu
- Matteo de Leon, BS · Contact224-864-0044Z1927462@students.niu.edu
Study team
Sponsor
Northern Illinois University
Study ID #HS25-0236
Principal investigator
Clayton Camic, PHD
Northern Illinois University
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.